| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.345 | 19.651 | 21.681 | 18.143 | 20.333 | 23.432 | 20.511 | 20.898 | 22.433 | 20.612 |
| Total Income - EUR | 24.371 | 19.727 | 21.731 | 18.143 | 20.333 | 23.434 | 20.521 | 20.917 | 22.446 | 20.631 |
| Total Expenses - EUR | 7.027 | 14.073 | 20.520 | 14.182 | 12.013 | 14.370 | 11.719 | 15.090 | 15.021 | 10.328 |
| Gross Profit/Loss - EUR | 17.344 | 5.655 | 1.211 | 3.961 | 8.320 | 9.064 | 8.802 | 5.826 | 7.425 | 10.303 |
| Net Profit/Loss - EUR | 16.613 | 5.063 | 168 | 3.417 | 7.710 | 8.431 | 8.199 | 5.211 | 6.415 | 8.688 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 |
Check the financial reports for the company - Medmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.380 | 12.949 | 8.894 | 6.917 | 3.002 | 5.911 | 5.412 | 4.420 | 3.401 | 2.475 |
| Current Assets | 52.131 | 33.279 | 34.480 | 38.950 | 9.172 | 3.375 | 3.648 | 3.618 | 7.272 | 14.358 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 48.697 | 24.222 | 22.885 | 37.606 | 6.024 | 1.179 | 496 | 0 | 1.480 | 4.803 |
| Cash | 3.434 | 9.057 | 11.596 | 1.344 | 3.148 | 2.196 | 3.152 | 3.618 | 5.792 | 9.555 |
| Shareholders Funds | 55.142 | 36.283 | 35.837 | 38.596 | 7.871 | 8.927 | 8.416 | 7.464 | 10.242 | 8.821 |
| Social Capital | 45 | 45 | 44 | 43 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 369 | 9.945 | 7.537 | 7.270 | 4.303 | 358 | 644 | 574 | 431 | 8.012 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medmed Srl